Re‐programming CHO cell metabolism using miR‐23 tips the balance towards a highly productive phenotype
Abstract
microRNA engineering of CHO cells has already proved successful in enhancing various industrially relevant phenotypes and producing various recombinant products. A single miRNA's ability to interact with multiple mRNA targets allows their regulatory capacity to extend to processes such as cellular metabolism. Various metabolic states have previously been associated with particular CHO cell phenotypes such as glycolytic or oxidative metabolism accommodating growth and productivity, respectively. miR-23 has previously been demonstrated to play a role in glutamate metabolism resulting in enhanced oxidative phosphorylation through the TCA cycle. Re-programming cellular bioenergetics through miR-23 could tip the balance, forcing mammalian production cells to be more productive by favoring metabolic channelling into oxidative metabolism. CHO clones depleted of miR-23 using a miR-sponge decoy demonstrated an average ∼three-fold enhanced specific productivity with no impact on cell growth. Using a cell respirometer, mitochondrial activity was found to be enhanced by ∼30% at Complex I and II of the electron transport system. Additionally, label-free proteomic analysis uncovered various potential novel targets of miR-23 including LE1 and IDH1, both implicated in oxidative metabolism and mitochondrial activity. These results demonstrate miRNA-based engineering as a route to re-programming cellular metabolism resulting in increased productivity, without affecting growth.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Proteomics analysis indicates that miR-23 can enhance oxidative metabolism and mitochondrial activity through multiple targets, altering the balance of mammalian production cells and increasing productivity.
“Proteomics analysis indicates that it can enhance oxidative metabolism and mitochondrial activity through multiple targets, thereby altering the balance of mammalian production cells and increasing productivity [24].”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [24]
miR-23 can readjust the biological ability of Chinese hamster ovary (CHO) cells.
“In terms of other metabolic regulation, it has been observed that miR-23 can readjust the biological ability of Chinese hamster ovary (CHO) cells.”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [24]
Cites
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Dang, C. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3556 · Cited by 379 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Recent advances of miR-23 in human diseases and growth development
Qian, X., Jiang, Y., Yang, Y., Zhang, Y., Xu, N., Xu, B., Pei, K., Yu, Z., & Wu, W. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.12.010 · Cited by 5 · see citing works
- Authors
- Kelly, P. S., Breen, L., Gallagher, C., Kelly, S., Henry, M., Lao, N. T., Meleady, P., O'Gorman, D., Clynes, M., & Barron, N.
- Affiliations
- Dublin City University (IE)
- Corresponding author
- Kelly, Paul S.
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2015-06-24
- Volume
- 10
- Issue
- 7
- Pages
- 1029-1040
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W1485008941
- Cited by
- 49
- References
- 2
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 7 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 5 · 2017: 9 · 2016: 3 · 2015: 2
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science Foundation Ireland (07/IN.1/B1323)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Keywords
- miR-23, CHO cells, oxidative metabolism, glycolytic metabolism, recombinant protein productivity, mitochondrial respiration, electron transport chain, glutamate metabolism, TCA cycle, IDH1, label-free quantitative proteomics
- MeSH terms
- Alkaline Phosphatase, Animals, Cricetulus, Cricetinae, Humans, Isocitrate Dehydrogenase, Mitochondria, Phenotype, RNA, Messenger, CHO Cells, Glutamic Acid, RNA Stability, MicroRNAs, Proteomics, Cell Proliferation, Cell Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review